Aster DM Healthcare has strengthened its position in Prerana Hospital Limited through a strategic acquisition that increases its ownership stake to 98.92%. The healthcare company acquired an additional 11.94% stake in the hospital for ₹38.36 crores, marking a significant step toward complete ownership of the facility.

Acquisition Details

The transaction details highlight the company's systematic approach to expanding its hospital network:

Strategic Expansion Timeline

The acquisition follows a phased approach, with Aster DM Healthcare planning to complete full ownership of Prerana Hospital Limited by December 31, 2026. The remaining 1.08% stake will be acquired within this timeline, ensuring complete control over the hospital's operations and strategic direction.

Healthcare Network Strengthening

This acquisition represents Aster DM Healthcare's continued focus on expanding its presence in the Indian healthcare market. By increasing its stake in Prerana Hospital Limited to near-complete ownership, the company demonstrates its commitment to building a robust hospital network through strategic investments in existing healthcare infrastructure.

The transaction value of ₹38.36 crores for an 11.94% stake reflects the company's willingness to invest substantially in quality healthcare assets, positioning itself for enhanced operational control and potential synergies within its broader healthcare ecosystem.

Aster DM Healthcare Limited has issued an important clarification regarding its recent media announcement about a proposed healthcare development project in Kerala. The clarification, filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, addresses the company's December 18 media release.

Project Details and Clarification

The clarification pertains to the media release titled "Aster DM Healthcare announces ₹125 crore healthcare development project in Kottakkal, Kerala" issued by the company on December 18. The proposed investment is planned for Kottakkal, Kerala, representing a significant healthcare infrastructure development initiative.

Corporate Approval Requirements

The company has emphasized that the announced proposal is subject to obtaining relevant corporate approvals before proceeding. The required approvals include:

• Approval of the Board of Directors of Aster DM Healthcare Limited
• Approval of the Board of Directors of Malabar Institute of Medical Sciences Limited (subsidiary)

Aster DM Healthcare has committed to making further disclosures as appropriate once requisite corporate approvals are obtained for the proposed investment, in terms of Regulation 30 of the Listing Regulations and other applicable provisions.

Regulatory Compliance and Communication

The clarification document was addressed to both the BSE Limited and The National Stock Exchange of India Limited on December 20. The company stated that this clarification is issued in the interest of transparent communication with stakeholders, advising investors and market participants to take note of the approval requirements.

The clarification was signed by Hemish Purushottam, Company Secretary and Compliance Officer, emphasizing the company's commitment to regulatory compliance and stakeholder transparency regarding the proposed healthcare development project.